Loading clinical trials...
Loading clinical trials...
Combined Retinoic Acid,Arsenic Trioxide and Chemotherapy for Newly-diagnosed Acute Promyelocytic Leukemia: Chinese National Multi-center Randomized Study
Conditions
Interventions
ATRA+Arsenic
ATRA+Chemo
Locations
1
China
Department of Hematology
Shanghai, China
Start Date
June 1, 2012
Primary Completion Date
December 31, 2020
Completion Date
December 31, 2020
Last Updated
August 19, 2019
NCT00003861
NCT03624270
NCT04251754
NCT02899169
NCT03096496
NCT01445080
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions